Jim Cramer says that investors should hold their horses for the time being.
He noted during TheStreet's live show Tuesday morning that Johnson & Johnson had broken above $140.
Cramer noted that a reason that he's cautious about the stock is because Johnson & Johnson is facing a court date over claims that its a 'kingpin' in the opioid crisis.
The trial is set to take place in May in Oklahoma.
Cramer said that he expects the trial to drive the share price down, so any investors who are looking to invest in Johnson & Johnson should wait to buy.
"If you haven't bought [shares of Johnson & Johnson] yet," Cramer said. "Wait."